These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 3029463

  • 1. [Clinical application of beta-lactamase inhibitors on urinary tract infections].
    Ohkawa M.
    Nihon Rinsho; 1986 Dec; 44(12):2573-7. PubMed ID: 3029463
    [No Abstract] [Full Text] [Related]

  • 2. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M, Ito T.
    Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME, Fu KP, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 Mar; 13(3):145-8. PubMed ID: 3040368
    [Abstract] [Full Text] [Related]

  • 4. [Beta-lactamase inhibitors. I. In vivo evaluation of an amoxicillin + clavulanic acid combination in the treatment of urinary infections].
    Dalet F, Del Río G.
    Rev Clin Esp; 1984 Feb 15; 172(3):153-7. PubMed ID: 6609385
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V, Horcicková M, Hatala M, Liska M, Matousovic K.
    Cas Lek Cesk; 1985 Jun 07; 124(23):711-4. PubMed ID: 3874692
    [No Abstract] [Full Text] [Related]

  • 8. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F, Li J, Gao L, Chen Y.
    Chin Med J (Engl); 1998 Nov 07; 111(11):1039-43. PubMed ID: 11189212
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
    Shiono A, Kurihara J, Hayashi M, Suzuki T, Imai K, Yamanaka H, Takezawa Y, Kiren H, Okabe K, Tomaru Y.
    Hinyokika Kiyo; 1993 Aug 07; 39(8):777-82. PubMed ID: 8379483
    [Abstract] [Full Text] [Related]

  • 10. The effects of three beta-lactamase inhibitors: YTR830H, sulbactam and clavulanic acid on the growth of human cells in culture.
    Yamabe S, Adachi K, Watanabe M, Ueda S.
    Chemioterapia; 1987 Oct 07; 6(5):337-40. PubMed ID: 2827899
    [Abstract] [Full Text] [Related]

  • 11. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
    Moosdeen F, Williams J, Yamabe S.
    Chemioterapia; 1987 Jun 07; 6(2 Suppl):206-7. PubMed ID: 2855613
    [No Abstract] [Full Text] [Related]

  • 12. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE.
    J Chemother; 1989 Jul 07; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract] [Full Text] [Related]

  • 13. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb 07; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 14. [Beta-lactamase inhibitors].
    Gialdroni Grassi G.
    G Ital Chemioter; 1982 Feb 07; 29(1):1-10. PubMed ID: 6764431
    [No Abstract] [Full Text] [Related]

  • 15. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
    Uzuka Y, Matsumoto K.
    Nihon Rinsho; 1986 Apr 07; 44(4):824-30. PubMed ID: 3531574
    [No Abstract] [Full Text] [Related]

  • 16. [beta-Lactamase-inhibitor combinations].
    Nakano R, Okamoto R.
    Nihon Rinsho; 2003 Mar 07; 61 Suppl 3():221-6. PubMed ID: 12717975
    [No Abstract] [Full Text] [Related]

  • 17. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar 07; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 18. [Beta lactamase inhibitors, a new start of antibiotic therapy].
    Wundt W, Baumgärtner M.
    Dtsch Med Wochenschr; 1982 Aug 27; 107(34):1285-9. PubMed ID: 6286267
    [No Abstract] [Full Text] [Related]

  • 19. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
    Campos M, Alarcón MA, González H, Sánchez R.
    Microbios; 1993 Aug 27; 76(308):171-9. PubMed ID: 8302198
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic properties of beta-lactamase inhibitors.
    de la Pena A, Derendorf H.
    Int J Clin Pharmacol Ther; 1999 Feb 27; 37(2):63-75. PubMed ID: 10082170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.